The effects of different dosages of combined antiepileptic drugs on their metabolism and their levels in body fluids
- 1 January 1974
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 77 (3-4) , 168-179
- https://doi.org/10.1016/0303-8467(74)90002-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Primidone, diphenylhydantoin and phenobarbitalNeurology, 1973
- Diphenylhydantoin: Efficacy, toxicity, and dose-serum level relationships in childrenThe Journal of Pediatrics, 1972
- Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administrationNeurology, 1972
- Phenylethylmalonamide (PEMA)Archives of Neurology, 1972
- Diphenylhydantoin (Dilantin®) and phenobarbital blood levels in epileptic childrenNeurology, 1971
- Micro-determination of serum phenobarbitone and diphenylhydantoin by gas-liquid chromatographyClinica Chimica Acta; International Journal of Clinical Chemistry, 1970
- Disappearance of phenobarbital and diphenylhydantoin from serum of childrenClinical Pharmacology & Therapeutics, 1970
- Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatographyClinica Chimica Acta; International Journal of Clinical Chemistry, 1970
- The rate of decline of diphenylhydantoin in human plasmaClinical Pharmacology & Therapeutics, 1970
- THE INFLUENCE OF PHENOBARBITAL ON THE HALF‐LIFE OF DIPHENYLHYDANTOIN IN MANActa Medica Scandinavica, 1969